Association between deployment and Gulf War Illness and adverse COVID outcomes in a nationwide cohort of 1990–1991 Gulf Era war veterans in the VA’s Million Veteran Program
PLOS One · 15.06.2026 · 21 (6) · e0348594
DOI: 10.1371/journal.pone.0348594 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 15.06.2026. Verfasst von Donna L White und 12 weiteren Autor:innen. Beteiligte Einrichtung: VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas, United States of…. Hauptthemen laut MEDLINE: COVID-19, Veterans, Persian Gulf Syndrome. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Background
U.S. military veterans deployed to the Persian Gulf to serve in the 1990–1991 Gulf War (GWVs) have expressed concerns about potential increased risk of experiencing adverse COVID-related health outcomes given broad near-unique exposure to multiple diverse toxic agents during deployment and ongoing ~30% prevalence of Gulf War Illness (GWI+), a chronic, medically unexplained multi-symptom disorder associated with inflammation and immune dysregulation.
Methods
We conducted a retrospective study in the largest nationwide research cohort of 1990−1991Gulf War era veterans (GWEVs) enrolled in the VA’s nationwide Million Veteran Program (MVP) to interrogate: 1) if deployed GWVs had increased risk for testing positive for novel SARS-CoV-2 infection (COVID+), COVID-related hospitalization, ICU admission, or death in 2020 (pre-vaccine period); and 2) if deployed GWVs with GWI + had particularly increased susceptibility. COVID outcomes ascertained using VA’s COVID Data Resource; GWI + determined using CDC severe criteria in surveyed GWV subcohort.
Findings
Our overall GWEV cohort (N = 136,868) had mean age 60.7 years, with 84% male, 27% African-American, and 22% deployed; n = 26,141 COVID-tested in 2020. COVID test-positivity (COVID + ) was slightly higher in deployed GWVs (18.8% vs. 17.2% in non-deployed GWEVs, p = 0.005). In multivariable logistic models, there were neither strong nor significant associations between deployment and testing COVID + , COVID-related hospitalization or ICU admission (adjusted [adj] ORs ranged from 0.90–1.06, all p-values >0.05), nor significant differences in COVID-related mortality. Preliminary analysis in our pre-pandemic surveyed deployed GWV subcohort (N = 1,643 COVID-tested, 39% GWI + , 18.4% testing-COVID + , 10.6% COVID + hospitalized) suggested GWI + potentially associated with significantly increased COVID-hospitalization risk (adjOR=2.21, 95%CI: 1.02–4.81, p = 0.04); though no significant excess was observed for COVID-related ICU admission or mortality.
Conclusions
Our findings demonstrated that overall deployment to serve in the 1990–1991 Gulf War was not associated with increased COVID-related health risks among Gulf War era veterans using VA healthcare system in early pre-vaccine pandemic era. Preliminary findings suggesting association between Gulf War Illness and potential increased COVID-related hospitalization risk among deployed Gulf War veterans in the early pandemic era warrants replication and ongoing evaluation to assess if it persists in the era of COVID vaccination, oral anti-COVID medications and new viral variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas, United States of America.
- Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
- Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, Texas, United States of America.
- Center for Translational Research in Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, Texas, United States of America.
- VA Cooperative Studies Program Epidemiology Center-Durham, Department of Veterans Affairs, Durham, North Carolina, United States of America.
- Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.
ORCID-Profile: Donna L White, Alice B S NonoDjotsa, Sarah T Ahmed, Elizabeth R Hauser
Förderung
- U.S. Department of Veterans Affairs
Zitieren
APA
White, D. L., NonoDjotsa, A. B. S., Ahmed, S. T., Boyle, S. H., Gaziano, J. M., Thompson, A. D., Johnson, M. G., Gifford, E. J., Polimanti, R., Aslan, M., Hauser, E. R., Helmer, D. A., & Million Veterans Program (MVP) (2026). Association between deployment and Gulf War Illness and adverse COVID outcomes in a nationwide cohort of 1990–1991 Gulf Era war veterans in the VA’s Million Veteran Program. PLOS One, 21(6), e0348594. https://doi.org/10.1371/journal.pone.0348594
Vancouver
White DL, NonoDjotsa ABS, Ahmed ST, Boyle SH, Gaziano JM, Thompson AD, et al. Association between deployment and Gulf War Illness and adverse COVID outcomes in a nationwide cohort of 1990–1991 Gulf Era war veterans in the VA’s Million Veteran Program. PLOS One. 2026;21(6):e0348594. doi:10.1371/journal.pone.0348594
BibTeX
@article{White2026,
author = {White, Donna L and NonoDjotsa, Alice B S and Ahmed, Sarah T and Boyle, Stephen H and Gaziano, J Michael and Thompson, Andrew D and Johnson, Melissa G and Gifford, Elizabeth J and Polimanti, Renato and Aslan, Mihaela and Hauser, Elizabeth R and Helmer, Drew A and Million Veterans Program (MVP), Million Veterans Program (MVP)},
title = {Association between deployment and Gulf War Illness and adverse COVID outcomes in a nationwide cohort of 1990–1991 Gulf Era war veterans in the VA’s Million Veteran Program},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0348594},
doi = {10.1371/journal.pone.0348594}
}
EUVIMED